What we offer our industry partners, physicians and patients:
As a pioneer in bringing clinical trials closer to patients in the community independent from academic resources, Sarah Cannon has built one of the largest early-phase clinical trial programs in the world, and has initiated more than 220 first-in-human trials to date.
A trusted partner to the leading pharmaceutical and biotech companies developing the newest cancer therapies, our physician leaders have been at the forefront of shaping the standard of care through new drug approvals for more than 20 years.
Sarah Cannon’s team has one of the broadest perspectives on cancer care delivery by reaching more than 100,000 newly diagnosed patients annually through our international network and enrolling thousands of patients into clinical trials annually.
Focused 100% on the patient, Sarah Cannon offers individualized plans to support and navigate those living with cancer with Sarah Cannon Nurse Navigators who have special training on specific cancer types.
Physician-led, Sarah Cannon’s network of physicians oversee quality standards and program development to build centers of excellence for every major cancer type that are recognized by the top accrediting organizations in cancer.
Sarah Cannon’s integrated delivery of cancer care is supported by custom technology that enables tracking and measuring of patient data to obtain better care outcomes.